Investigational Drug Information for Arbaclofen placarbil
✉ Email this page to a colleague
What is the development status for investigational drug Arbaclofen placarbil?
Arbaclofen placarbil is an investigational drug.
There have been 6 clinical trials for Arbaclofen placarbil.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2011.
The most common disease conditions in clinical trials are Gastroesophageal Reflux, Alcoholism, and Alcohol Drinking. The leading clinical trial sponsors are Indivior Inc., XenoPort, Inc., and [disabled in preview].
Summary for Arbaclofen placarbil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 66 |
| WIPO Patent Applications | 28 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 3 (2011-05-01) |
| Vendors | 23 |
Recent Clinical Trials for Arbaclofen placarbil
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers | Indivior Inc. | Phase 1 |
| A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder | Indivior Inc. | Phase 2 |
| Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis | Indivior Inc. | Phase 3 |
Clinical Trial Summary for Arbaclofen placarbil
Top disease conditions for Arbaclofen placarbil
Top clinical trial sponsors for Arbaclofen placarbil
US Patents for Arbaclofen placarbil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
